Biden feels well, still tests positive for COVID-19 - doctor
Reuters
Published Aug 05, 2022 12:05PM ET
Updated Aug 05, 2022 03:55PM ET
WASHINGTON (Reuters) - U.S. President Joe Biden continues to feel "very well" while still testing positive for COVID-19, the White House physician said on Friday.
Biden will continue strict isolation measures and work from home, Dr. Kevin O'Connor said in a memo.
"The president continues to feel very well. His cough has almost completely resolved. His temperature, pulse, blood pressure, respiratory rate and oxygen saturation remain entirely normal. His lungs remain clear," O'Connor wrote.
Biden, 79, had just emerged from isolation on Wednesday last week after testing positive for COVID for the first time on July 21. He tested positive again on Saturday in what O'Connor described as a "rebound" case seen in a small percentage of patients who take the antiviral drug Paxlovid.
Paxlovid is an antiviral medication from Pfizer Inc (NYSE:PFE) that is used to treat high-risk patients, such as older patients.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.